By expenditures
| Name | Title | Type |
|---|---|---|
| Steven Nicholson | Director of Financial Planning & Analysis NSABP Foundation | Auditee |
| Julie Kardell | Senior Director Of Finance | Auditee |
| Amy C. Lewis | Engagement Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 368734 | 2024 | 2025-09-29 | Maher Duessel CPAS | $4.16M |
| 326962 | 2023 | 2024-11-01 | Maher Duessel CPAS | $4.28M |
| 302833 | 2022 | 2024-04-08 | Maher Duessel CPAS | $4.25M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 326962 | 2023 | 2024-11-01 | 1080846 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 1080845 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 1080844 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 1080843 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 1080842 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 1080841 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 1080840 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 1080839 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 1080838 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 1080837 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 1080836 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 1080835 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 504404 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 504403 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 504402 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 504401 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 504400 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 504399 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 504398 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 504397 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 504396 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 504395 | 2023-001 | Significant Deficiency | Yes | P |
| 326962 | 2023 | 2024-11-01 | 504394 | 2023-002 | Material Weakness | Yes | M |
| 326962 | 2023 | 2024-11-01 | 504393 | 2023-001 | Significant Deficiency | Yes | P |
| 302833 | 2022 | 2024-04-08 | 968947 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 968946 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 968945 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 968944 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 968943 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 968942 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 968941 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 968940 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 968939 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 968938 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 968937 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 968936 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 968935 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 968934 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 392505 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 392504 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 392503 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 392502 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 392501 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 392500 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 392499 | 2022-002 | Material Weakness | - | M |
| 302833 | 2022 | 2024-04-08 | 392498 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 392497 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 392496 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 392495 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 392494 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 392493 | 2022-001 | Significant Deficiency | - | P |
| 302833 | 2022 | 2024-04-08 | 392492 | 2022-001 | Significant Deficiency | - | P |